The DOI matches its Crossref record; 115 of the 115 references it cites were found in a registry or an index.
Recent Advances in Cell Penetrating Peptide-Based Anticancer Therapies
Open accessAbstract
Cell-penetrating-peptides (CPPs) are small amino-acid sequences characterized by their ability to cross cellular membranes. They can transport various bioactive cargos inside cells including nucleic acids, large proteins, and other chemical compounds. Since 1988, natural and synthetic CPPs have been developed for applications ranging from fundamental to applied biology (cell imaging, gene editing, therapeutics delivery). In recent years, a great number of studies reported the potential of CPPs as carriers for the treatment of various diseases. Apart from a good efficacy due to a rapid and potent delivery, a crucial advantage of CPP-based therapies is the peptides low toxicity compared to most drug carriers. On the other hand, they are quite unstable and lack specificity. Higher specificity can be obtained using a cell-specific CPP to transport the therapeutic agent or using a non-specific CPP to transport a cargo with a targeted activity. CPP-cargo complexes can also be conjugated to another moiety that brings cell- or tissue-specificity. Studies based on all these approaches are showing promising results. Here, we focus on recent advances in the potential usage of CPPs in the context of cancer therapy, with a particular interest in CPP-mediated delivery of anti-tumoral proteins.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
In Vivo Protein Transduction: Delivery of a Biologically Active Protein into the Mouse
Schwarze, S. R., Ho, A., Vocero-Akbani, A., & Dowdy, S. F. (1999) · Science · doi:10.1126/science.285.5433.1569 · Cited by 2,416
The third helix of the Antennapedia homeodomain translocates through biological membranes.
Derossi, D., Joliot, A. H., Chassaing, G., & Prochiantz, A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)34080-2 · Cited by 2,034
Wender, P. A., Mitchell, D. J., Pattabiraman, K., Pelkey, E. T., Steinman, L., & Rothbard, J. B. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.24.13003 · Cited by 1,615
Pathways of clathrin-independent endocytosis
Mayor, S., & Pagano, R. E. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2216 · Cited by 1,556
Green, M., & Loewenstein, P. M. (1988) · Cell · doi:10.1016/0092-8674(88)90262-0 · Cited by 1,553
Baar, M. P., Brandt, R. M. C., Putavet, D. A., Klein, J. D. D., Derks, K. W. J., Bourgeois, B. R. M., Stryeck, S., Rijksen, Y., van Willigenburg, H., Feijtel, D. A., et al. (2017) · Cell · doi:10.1016/j.cell.2017.02.031 · Cited by 1,454
Tumor angiogenesis and vascular normalization: alternative therapeutic targets
Viallard, C., & Larrivée, B. (2017) · Angiogenesis · doi:10.1007/s10456-017-9562-9 · Cited by 1,424
Cell-Penetrating Peptides: From Basic Research to Clinics
Guidotti, G., Brambilla, L., & Rossi, D. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.01.003 · Cited by 1,147
A peptide carrier for the delivery of biologically active proteins into mammalian cells
Morris, M. C., Depollier, J., Mery, J., Heitz, F., & Divita, G. (2001) · Nature Biotechnology · doi:10.1038/nbt1201-1173 · Cited by 1,018
Mechanisms of Cellular Uptake of Cell-Penetrating Peptides
Madani, F., Lindberg, S., Langel, Ü., Futaki, S., & Gräslund, A. (2011) · Journal of Biophysics · doi:10.1155/2011/414729 · Cited by 984
Cell-Penetrating Peptides: Design, Synthesis, and Applications
Copolovici, D. M., Langel, K., Eriste, E., & Langel, Ü. (2014) · ACS Nano · doi:10.1021/nn4057269 · Cited by 963
Cell‐penetrating peptides: 20 years later, where do we stand?
Bechara, C., & Sagan, S. (2013) · FEBS Letters · doi:10.1016/j.febslet.2013.04.031 · Cited by 857
A Comprehensive Model for the Cellular Uptake of Cationic Cell‐penetrating Peptides
Duchardt, F., Fotin‐Mleczek, M., Schwarz, H., Fischer, R., & Brock, R. (2007) · Traffic · doi:10.1111/j.1600-0854.2007.00572.x · Cited by 771
Cell penetration by transportan
Pooga, M., Hällbrink, M., Zorko, M., & Langel, U. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.1.67 · Cited by 679
Current Trends in The Use of Liposomes for Tumor Targeting
Deshpande, P. P., Biswas, S., & Torchilin, V. P. (2013) · Nanomedicine · doi:10.2217/nnm.13.118 · Cited by 657
Antennapedia homeobox peptide regulates neural morphogenesis.
Joliot, A., Pernelle, C., Deagostini-Bazin, H., & Prochiantz, A. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.5.1864 · Cited by 654
The Dual Roles of NRF2 in Cancer
Menegon, S., Columbano, A., & Giordano, S. (2016) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2016.05.002 · Cited by 633
Richard, J. P., Melikov, K., Brooks, H., Prevot, P., Lebleu, B., & Chernomordik, L. V. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m401604200 · Cited by 604
A new peptide vector for efficient delivery of oligonucleotides into mammalian cells
Morris, M. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.14.2730 · Cited by 535
Arginine‐rich cell‐penetrating peptides
Schmidt, N., Mishra, A., Lai, G. H., & Wong, G. C. L. (2010) · FEBS Letters · doi:10.1016/j.febslet.2009.11.046 · Cited by 521
El-Sayed, A., Futaki, S., & Harashima, H. (2009) · The AAPS Journal · doi:10.1208/s12248-008-9071-2 · Cited by 465
Tat Protein from Human Immunodeficiency Virus Forms a Metal-Linked Dimer
Frankel, A. D., Bredt, D. S., & Pabo, C. O. (1988) · Science · doi:10.1126/science.2832944 · Cited by 457
Oehlke, J., Scheller, A., Wiesner, B., Krause, E., Beyermann, M., Klauschenz, E., Melzig, M., & Bienert, M. (1998) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(98)00161-8 · Cited by 448
Tünnemann, G., Martin, R. M., Haupt, S., Patsch, C., Edenhofer, F., & Cardoso, M. C. (2006) · The FASEB Journal · doi:10.1096/fj.05-5523com · Cited by 402
ERK activation upon hypoxia: involvement in HIF‐1 activation
Minet, E., Arnould, T., Michel, G., Roland, I., Mottet, D., Raes, M., Remacle, J., & Michiels, C. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01181-9 · Cited by 379
Caveolae-Mediated internalization of extracellular HIV-1 tat fusion proteins visualized in real time
Ferrari, A., Pellegrini, V., Arcangeli, C., Fittipaldi, A., Giacca, M., & Beltram, F. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(03)00122-9 · Cited by 335
CPPsite 2.0: a repository of experimentally validated cell-penetrating peptides
Agrawal, P., Bhalla, S., Usmani, S. S., Singh, S., Chaudhary, K., Raghava, G. P. S., & Gautam, A. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1266 · Cited by 332
EL Andaloussi, S., Lehto, T., Mäger, I., Rosenthal-Aizman, K., Oprea, I. I., Simonson, O. E., Sork, H., Ezzat, K., Copolovici, D. M., Kurrikoff, K., et al. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq1299 · Cited by 301
VE-Cadherin-Derived Cell-Penetrating Peptide, pVEC, with Carrier Functions
Elmquist, A., Lindgren, M., Bartfai, T., & Langel, Ü. (2001) · Experimental Cell Research · doi:10.1006/excr.2001.5316 · Cited by 290
Cell-Penetrating Peptides—Mechanisms of Cellular Uptake and Generation of Delivery Systems
Trabulo, S., Cardoso, A. L., Mano, M., & De Lima, M. C. P. (2010) · Pharmaceuticals · doi:10.3390/ph3040961 · Cited by 290
Nischan, N., Herce, H. D., Natale, F., Bohlke, N., Budisa, N., Cardoso, M. C., & Hackenberger, C. P. R. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201410006 · Cited by 287
Olson, E. S., Aguilera, T. A., Jiang, T., Ellies, L. G., Nguyen, Q. T., Wong, E. H., Gross, L. A., & Tsien, R. Y. (2009) · Integrative Biology · doi:10.1039/b904890a · Cited by 263
Cell-penetrating peptides transport therapeutics into cells
Ramsey, J. D., & Flynn, N. H. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.07.003 · Cited by 256
Cellular siRNA delivery using cell-penetrating peptides modified for endosomal escape
Endoh, T., & Ohtsuki, T. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.04.005 · Cited by 242
Allolio, C., Magarkar, A., Jurkiewicz, P., Baxová, K., Javanainen, M., Mason, P. E., Šachl, R., Cebecauer, M., Hof, M., Horinek, D., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1811520115 · Cited by 235
Pasqualini, R., Koivunen, E., & Ruoslahti, E. (1995) · The Journal of cell biology · doi:10.1083/jcb.130.5.1189 · Cited by 234
In vitro and in vivo delivery of therapeutic proteins using cell penetrating peptides
Bolhassani, A., Jafarzade, B. S., & Mardani, G. (2017) · Peptides · doi:10.1016/j.peptides.2016.11.011 · Cited by 234
Zhang, D., Wang, J., & Xu, D. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.03.020 · Cited by 227
PEGylated enhanced cell penetrating peptide nanoparticles for lung gene therapy
Osman, G., Rodriguez, J., Chan, S. Y., Chisholm, J., Duncan, G., Kim, N., Tatler, A. L., Shakesheff, K. M., Hanes, J., Suk, J. S., et al. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.07.001 · Cited by 208
Cyclin B1 depletion inhibits proliferation and induces apoptosis in human tumor cells
Yuan, J., Yan, R., Krämer, A., Eckerdt, F., Roller, M., Kaufmann, M., & Strebhardt, K. (2004) · Oncogene · doi:10.1038/sj.onc.1207757 · Cited by 203
A non-covalent peptide-based strategy for protein and peptide nucleic acid transduction
Gros, E., Deshayes, S., Morris, M. C., Aldrian-Herrada, G., Depollier, J., Heitz, F., & Divita, G. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.02.006 · Cited by 189
Noncationic Peptides Obtained From Azurin Preferentially Enter Cancer Cells
Taylor, B. N., Mehta, R. R., Yamada, T., Lekmine, F., Christov, K., Chakrabarty, A. M., Green, A., Bratescu, L., Shilkaitis, A., Beattie, C. W., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2932 · Cited by 184
Nakase, I., Noguchi, K., Aoki, A., Takatani-Nakase, T., Fujii, I., & Futaki, S. (2017) · Scientific Reports · doi:10.1038/s41598-017-02014-6 · Cited by 182
Cell-penetrating peptides: Possible transduction mechanisms and therapeutic applications
GUO, Z., PENG, H., KANG, J., & SUN, D. (2016) · Biomedical Reports · doi:10.3892/br.2016.639 · Cited by 169
Nanoparticles for Cancer Targeting: Current and Future Directions
Swain, S., Sahu, P., Beg, S., & Babu, S. (2016) · Current Drug Delivery · doi:10.2174/1567201813666160713121122 · Cited by 169
Emerging Methods and Design Principles for Cell‐Penetrant Peptides
Peraro, L., & Kritzer, J. A. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201801361 · Cited by 160
Predicting cell-penetrating peptides
Hansen, M., Kilk, K., & Langel, Ü. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.09.003 · Cited by 157
Efficiency of Protein Transduction Is Cell Type-dependent and Is Enhanced by Dextran Sulfate
Mai, J. C., Shen, H., Watkins, S. C., Cheng, T., & Robbins, P. D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204202200 · Cited by 156
Nielsen, E. J. B., Yoshida, S., Kamei, N., Iwamae, R., Khafagy, E., Olsen, J., Rahbek, U. L., Pedersen, B. L., Takayama, K., & Takeda‐Morishita, M. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.06.022 · Cited by 151
RNA targeting with peptide conjugates of oligonucleotides, siRNA and PNA
Turner, J. J., Jones, S. W., Fabani, M. M., Ivanova, G. D., Arzumanov, A. A., & Gait, M. J. (2006) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2006.10.003 · Cited by 151
Matsuzaki, K., Sugishita, K.-I., & Miyajima, K. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00443-3 · Cited by 150
Lim, K. J., Sung, B. H., Shin, J. R., Lee, Y. W., Kim, D. J., Yang, K. S., & Kim, S. C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066084 · Cited by 131
A non-covalent peptide-based carrier for in vivo delivery of DNA mimics
Morris, M. C., Gros, E., Aldrian, G., Choob, M. V., Archdeacon, J., Heitz, F., & Divita, G. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm053 · Cited by 129
Fang, W. B., Yao, M., Brummer, G., Acevedo, D., Alhakamy, N. A., Berkland, C. J., & Cheng, N. (2016) · Oncotarget · doi:10.18632/oncotarget.9885 · Cited by 124
Membrane Crossing and Membranotropic Activity of Cell-Penetrating Peptides: Dangerous Liaisons?
Walrant, A., Cardon, S., Burlina, F., & Sagan, S. (2017) · Accounts of Chemical Research · doi:10.1021/acs.accounts.7b00455 · Cited by 121
Characterization of a Novel Cytotoxic Cell‐penetrating Peptide Derived From p14ARF Protein
Johansson, H. J., Andaloussi, S. E., Holm, T., Mäe, M. A., Jänes, J., Maimets, T., & Langel, Ü. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300346 · Cited by 119
Efficient Delivery of Quantum Dots into the Cytosol of Cells Using Cell-Penetrating Poly(disulfide)s
Derivery, E., Bartolami, E., Matile, S., & González‐Gaitán, M. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.7b02952 · Cited by 118
Mehta, R. R., Yamada, T., Taylor, B. N., Christov, K. T., King, M. L., Majumdar, D., Lekmine, F., Tiruppathì, C., Shilkaitis, A. L., Bratescu, L., et al. (2011) · Angiogenesis · doi:10.1007/s10456-011-9220-6 · Cited by 117
Cell-Penetrating Pepducin Therapy Targeting PAR1 in Subjects With Coronary Artery Disease
Gurbel, P. A., Bliden, K. P., Turner, S. E., Tantry, U. S., Gesheff, M. G., Barr, T. P., Covic, L., & Kuliopulos, A. (2015) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.115.306777 · Cited by 116
Anti-inflammatory Effect of a Cell-Penetrating Peptide Targeting the Nrf2/Keap1 Interaction
Steel, R., Cowan, J., Payerne, E., O'Connell, M. A., & Searcey, M. (2012) · ACS Medicinal Chemistry Letters · doi:10.1021/ml300041g · Cited by 113
RGD Peptide‐Based Target Drug Delivery of Doxorubicin Nanomedicine
Sun, Y., Chen, K., Liu, F., Zhou, Y., Luo, L., & Qiao, H. (2017) · Drug Development Research · doi:10.1002/ddr.21399 · Cited by 113
Cellular Import Mediated by Nuclear Localization Signal Peptide Sequences
Ragin, A. D., Morgan, R. A., & Chmielewski, J. A. (2002) · Chemistry & Biology · doi:10.1016/s1074-5521(02)00189-8 · Cited by 112
Cellular Uptake and Cytotoxicity of Drug–Peptide Conjugates Regulated by Conjugation Site
Zhang, P., Cheetham, A. G., Lock, L. L., & Cui, H. (2013) · Bioconjugate Chemistry · doi:10.1021/bc300585h · Cited by 107
Cell-Type Specific Penetrating Peptides: Therapeutic Promises and Challenges
Zahid, M., & Robbins, P. D. (2015) · Molecules · doi:10.3390/molecules200713055 · Cited by 98
Delaroche, D., Aussedat, B., Aubry, S., Chassaing, G., Burlina, F., Clodic, G., Bolbach, G., Lavielle, S., & Sagan, S. (2007) · Analytical Chemistry · doi:10.1021/ac061108l · Cited by 98
CPP-Assisted Intracellular Drug Delivery, What Is Next?
Ye, J., Liu, E., Yu, Z., Pei, X., Chen, S., Zhang, P., Shin, M. C., Gong, J., He, H., & Yang, V. C.-M. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17111892 · Cited by 97
Activable Cell-Penetrating Peptide Conjugated Prodrug for Tumor Targeted Drug Delivery
Cheng, H. B., Zhu, J., Xu, X., Qiu, W., Lei, Q., Han, K., Cheng, Y., & Zhang, X. (2015) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5b04517 · Cited by 96
The antiapoptotic protein AAC‐11 interacts with and regulates Acinus‐mediated DNA fragmentation
Rigou, P., Piddubnyak, V., Faye, A., Rain, J., Michel, L., Calvo, F. M., & Poyet, J. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.106 · Cited by 80
Self-citationA Mechanism-Based Cross-Linker for the Identification of Kinase−Substrate Pairs
Maly, D. J., Allen, J. J., & Shokat, K. M. (2004) · Journal of the American Chemical Society · doi:10.1021/ja048659i · Cited by 80
p28, A first in class peptide inhibitor of cop1 binding to p53
Yamada, T., Christov, K., Shilkaitis, A., Bratescu, L., Green, A., Santini, S., Bizzarri, A. R., Cannistraro, S., Gupta, T. K. D., & Beattie, C. W. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.266 · Cited by 78
Xiang, B., Jia, X., Qi, J., Yang, L., Sun, W., Yan, X., Yang, S., De-ying, C., Du, Q., & Qi, X. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s129574 · Cited by 78
Jia, L., Gorman, G. S., Coward, L. U., Noker, P. E., McCormick, D. L., Horn, T. L., Harder, J. B., Muzzio, M., Prabhakar, B. S., Ganesh, B. B., et al. (2010) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-010-1518-3 · Cited by 71
Cell-Penetrating Peptides: Possibilities and Challenges for Drug Delivery in Vitro and in Vivo
Skotland, T., Iversen, T., Torgersen, M. L., & Sandvig, K. (2015) · Molecules · doi:10.3390/molecules200713313 · Cited by 66
Langel, Ü., Pooga, M., Kairane, C., Zilmer, M., & Bartfai, T. (1996) · Regulatory Peptides · doi:10.1016/0167-0115(96)00002-x · Cited by 63
A Cell-Penetrating Peptide Targeting AAC-11 Specifically Induces Cancer Cells Death
Jagot-Lacoussiere, L., Pasquereau-Kotula, E., Villoutreix, B. O., Bruzzoni‐Giovanelli, H., & Poyet, J. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0302 · Cited by 62
Self-citationNickFects, Phosphorylated Derivatives of Transportan 10 for Cellular Delivery of Oligonucleotides
Oskolkov, N., Arukuusk, P., Copolovici, D. M., Lindberg, S., Margus, H., Padari, K., Pooga, M., & Langel, Ü. (2011) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-011-9252-1 · Cited by 59
Dimerization of a cell-penetrating peptide leads to enhanced cellular uptake and drug delivery
Hoyer, J., Schatzschneider, U., Schulz‐Siegmund, M., et al. (2012) · Beilstein Journal of Organic Chemistry · doi:10.3762/bjoc.8.204 · Cited by 58
The anticancer peptide RT53 induces immunogenic cell death
Pasquereau-Kotula, E., Habault, J., Kroemer, G., & Poyet, J. (2018) · PLoS ONE · doi:10.1371/journal.pone.0201220 · Cited by 58
Self-citationD ‐SAP: A New, Noncytotoxic, and Fully Protease Resistant Cell‐Penetrating Peptide
Pujals, S., Fernández‐Carneado, J., Ludevid, M. D., & Giralt, E. (2007) · ChemMedChem · doi:10.1002/cmdc.200700267 · Cited by 57
Ye, J., Shin, M. C., Liang, Q., He, H., & Yang, V. C.-M. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.12.002 · Cited by 56
Karagiota, A., Kourti, M., Simos, G., & Mylonis, I. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2985-7 · Cited by 56
Shin, M. C., Zhang, J., Min, K. A., Lee, K., Moon, C., Balthasar, J. P., & Yang, V. C.-M. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.08.030 · Cited by 54
The Current Role of Cell-Penetrating Peptides in Cancer Therapy
Feni, L., & Neundorf, I. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-66095-0_13 · Cited by 51
Shukla, G. S., & Krag, D. N. (2005) · Journal of drug targeting · doi:10.1080/10611860400020464 · Cited by 48
DARWISH, S. A. F., Sadeghiani, N., Fong, S., Mozaffari, S., Hamidi, P., Withana, T., Yang, S., Tiwari, R. K., & Parang, K. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.10.042 · Cited by 48
Szabó, I., Orbán, E., Schlosser, G., Hudecz, F., & Bánóczi, Z. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.03.034 · Cited by 42
“Soft” Calcium Crosslinks Enable Highly Efficient Gene Transfection Using TAT Peptide
Baoum, A. A., Xie, S., Fakhari, A., & Berkland, C. J. (2009) · Pharmaceutical Research · doi:10.1007/s11095-009-9976-1 · Cited by 41
Mandal, P. K., Biswas, S., Mandal, G., Purohit, S., Gupta, A., Majumdar, A., Chowdhury, S. R., & Bhattacharyya, A. (2017) · Immunobiology · doi:10.1016/j.imbio.2017.10.031 · Cited by 41
Kamada, H., Okamoto, T., Kawamura, M., Shibata, H., Abe, Y., Ohkawa, A., Nomura, T., Sato, M., Mukai, Y., Sugita, T., et al. (2007) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.30.218 · Cited by 39
Shahbazi, S., & Bolhassani, A. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.07.006 · Cited by 38
Novel peptide MT23 for potent penetrating and selective targeting in mouse melanoma cancer cells
Zhou, N., Wu, J., Qin, Y., Zhao, X., Ding, Y., Sun, L., He, T., Huang, X., Liu, C.-B., & Wang, H. (2017) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2017.08.011 · Cited by 37
Krejčı́, P., Pejchalova, K., Rosenbloom, B. E., et al. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0607425 · Cited by 36
Cyclic peptide-based nanostructures as efficient siRNA carriers
Panigrahi, B., Singh, R. K., Mishra, S., & Mandal, D. (2018) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2018.1511574 · Cited by 33
A peptide carrier for the delivery of elastin into fibroblast cells
Nasrollahi, S. A., Fouladdel, S., Taghibiglou, C., Azizi, E., & Farboud, E. S. (2012) · International Journal of Dermatology · doi:10.1111/j.1365-4632.2011.05214.x · Cited by 32
Yu, M., Li, X., Huang, X., Zhang, J., Zhang, Y., & Wang, H. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b21027 · Cited by 31
Lim, K. J., Sung, B. H., Shin, J. R., Lee, Y. W., Kim, D. J., Yang, K. S., & Kim, S. C. (2013) · PLoS ONE · doi:10.1371/annotation/fb854e6a-cc9e-4446-b50a-5318cffb68c5 · Cited by 31
Reprogramming the oncogenic response: SET protein as a potential therapeutic target in cancer
Hung, M., & Chen, K. (2017) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2017.1336226 · Cited by 30
Cell-Penetrating Peptides as Delivery Enhancers for Vaccine
Jiang, Y., Li, M., Zhang, Z., Gong, T., & Sun, X. (2014) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201015666140813130114 · Cited by 29
Vaccine delivery by penetratin: mechanism of antigen presentation by dendritic cells
Pouniotis, D. S., Tang, C.-K., Apostolopoulos, V., & Pietersz, G. A. (2016) · Immunologic Research · doi:10.1007/s12026-016-8799-5 · Cited by 29
A Synthetic Cell-Penetrating Peptide Antagonizing TrkA Function Suppresses Neuropathic Pain in Mice
Ma, W., Murata, E., Ueda, K., Kuroda, Y., Cao, M., Abe, M., Shigemi, K., & Hirose, M. (2010) · Journal of Pharmacological Sciences · doi:10.1254/jphs.10119fp · Cited by 27
Membrane Mechanics in Living Cells
Groves, J. T. (2019) · Developmental Cell · doi:10.1016/j.devcel.2018.12.011 · Cited by 27
Pouniotis, D. S., Apostolopoulos, V., & Pietersz, G. A. (2005) · Immunology · doi:10.1111/j.1365-2567.2005.02304.x · Cited by 25
Niu, X., Gao, Z., Qi, S., Su, L., Yang, N., Luan, X., Li, J., Zhang, Q., An, Y., & Zhang, S. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s171361 · Cited by 25
A Non-covalent Peptide-Based Strategy for Ex Vivo and In Vivo Oligonucleotide Delivery
Crombez, L., Morris, M. C., Heitz, F., & Divita, G. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-188-8_4 · Cited by 24
Using artificial neural networks to predict cell-penetrating compounds
Karelson, M. M., & Dobchev, D. A. (2011) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2011.586689 · Cited by 24
El‐Sayed, N. S., Miyake, T., Shirazi, A. N., Park, S. E., Clark, J., Buchholz, S., Parang, K., & Tiwari, R. K. (2018) · Molecules · doi:10.3390/molecules23071590 · Cited by 24
Improved anticancer efficacy of doxorubicin mediated by human-derived cell-penetrating peptide dNP2
Xiang, Y., Shan, W., & Huang, Y. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.09.011 · Cited by 24
Cellular uptake of the Antennapedia homeodomain polypeptide by macropinocytosis
Wu, X., & Gehring, W. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.12.062 · Cited by 22
Shirazi, A. N., Mozaffari, S., Sherpa, R. T., Tiwari, R. K., & Parang, K. (2018) · Molecules · doi:10.3390/molecules23071536 · Cited by 22
Targeting neuronal nitric oxide synthase by a cell penetrating peptide Tat-LK15/siRNA bioconjugate
Peng, J., Rao, Y., Yang, X. W., Jia, J., Wu, Y., Jianhua, L., Tao, Y., & Tu, W. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.04.045 · Cited by 21
Tian, L., Zhang, X., Haesen, D., Bravo, J., Fominaya, J. M., Choquet, S., Zini, J. M., Loisel, S., Waelkens, E., Janssens, V., et al. (2017) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-017-9633-1 · Cited by 20
Gurney, L., Taggart, J., Tong, W.-C., Jones, A. T., Robson, S. C., & Taggart, M. J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02966 · Cited by 18
Targeting AAC-11 in cancer therapy
Faye, A., & Poyet, J. (2009) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728220903431077 · Cited by 17
Self-citationBrooks, N. A., Hsu, J. L., Esparon, S. E., Pouniotis, D. S., & Pietersz, G. A. (2018) · Molecules · doi:10.3390/molecules23092233 · Cited by 17
Bullenkamp, J., & Tavassoli, M. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-1-4471-6458-6_2 · Cited by 9
Cited by
Xie, J., Bi, Y., Zhang, H., Dong, S., Teng, L., Lee, R. J., & Yang, Z. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00697 · Cited by 466
Internalization mechanisms of cell-penetrating peptides
Ruseska, I., & Zimmer, A. (2020) · Beilstein Journal of Nanotechnology · doi:10.3762/bjnano.11.10 · Cited by 436
Development of Polymeric Nanoparticles for Blood–Brain Barrier Transfer—Strategies and Challenges
Zhang, W., Mehta, A., Tong, Z., Esser, L., & Voelcker, N. H. (2021) · Advanced Science · doi:10.1002/advs.202003937 · Cited by 430
A Global Review on Short Peptides: Frontiers and Perspectives
Apostolopoulos, V., Bojarska, J., Chai, T.-T., Elnagdy, S., Kaczmarek, K., Matsoukas, J., New, R., Parang, K., Lopez, O. P., Parhiz, H., et al. (2021) · Molecules · doi:10.3390/molecules26020430 · Cited by 421
Li, Y., He, D., Li, B., Lund, M. N., Xing, Y., Wang, Y., Li, F., Cao, X., Liu, Y., Chen, X., et al. (2021) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2021.02.009 · Cited by 321
Metadata
- Authors
- Habault, J., & Poyet, J.-L.
- Venue
- Molecules
- Publisher
- MDPI AG
- Published
- 2019-03-07
- Volume
- 24
- Issue
- 5
- Pages
- 927
- ISSN
- 1420-3049 (ISSN-L)
- OpenAlex
- W2919285837
- Cited by
- 280
- References
- 115
- FWCI
- 12.17
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.